Moneycontrol PRO
thyrocare technologies
Jump to
37 Results Found
  • Buy or Sell | Thyrocare Technologies could return 20% Dec 23, 2019 03:04 PM IST

    Buy or Sell | Thyrocare Technologies could return 20%

    Dinesh Rohira Founder and CEO of 5nance.com is positive on Thyrocare Technologies and expects the company to grow.

  • See margins at 37-41% for coming qtrs; growth at 22% for next 2-3 years: Thyrocare Tech Feb 05, 2018 12:48 PM IST

    See margins at 37-41% for coming qtrs; growth at 22% for next 2-3 years: Thyrocare Tech

    Going forward for the next 2-3 years, the growth is expected at the rate of 22 percent, said A Velumani, Chairman, CEO and Managing Director, Thyrocare Technologies.

  • Would look to add 4 more regional processing labs, says Thyrocare Aug 14, 2017 10:45 AM IST

    Would look to add 4 more regional processing labs, says Thyrocare

    Thyrocare Technologies posted a good set of numbers this quarter. In an interview to CNBC-TV18, A Velumani, Chairman, MD & CEO of Thyrocare Technologies discussed the company's Q1 performance.

  • Wellness segment contributes majority of growth: Thyrocare's Velumani Jun 02, 2017 04:18 PM IST

    Wellness segment contributes majority of growth: Thyrocare's Velumani

    In an interview to CNBC-TV18, A Velumani, Chairman, CEO & MD of Thyrocare Technologies spoke about the results and his outlook for the company.

  • Traders Carnival: Watch A Velumani's rags to riches story May 09, 2017 08:52 AM IST

    Traders Carnival: Watch A Velumani's rags to riches story

    Watch A Velumani, Chairman and MD, Thyrocare sharing his rags to riches story at Traders Carnival 2017.

  • Luxury of Poverty: The making of Chennai Silks Mar 22, 2017 08:14 AM IST

    Luxury of Poverty: The making of Chennai Silks

    Luxury of Poverty focuses on the brave hearts who have won against all odds and stories that inspire people to become entrepreneurs. Dr A Velumani of Thyrocare Technologies is a perfect role model and so in many ways is better placed to comment and give views on entrepreneur's features. Luxury of Poverty focuses on The Chennai Silks, one of the largest retail outlet that sells sarees, dress materials and men's wear for over five decades.

  • Luxury of Poverty: Take a look at Balaji Wafers' story Mar 06, 2017 08:25 AM IST

    Luxury of Poverty: Take a look at Balaji Wafers' story

    Thyrocare Luxury of Poverty focuses on Chandubhai Virani, the man who built Balaji Wafers. It is a hard-earned success story. Chandubhai started as a gate-keeper at a cinema theatre in Rajkot some four decades ago. Today he has built a brand that is giving big players sleepless nights.

  • The Luxury of Poverty: Know more about Thyrocare's A Velumani Feb 20, 2017 04:48 PM IST

    The Luxury of Poverty: Know more about Thyrocare's A Velumani

    Know more about the Chairman of Thyrocare Technologies, Dr A Velumani in this of episode of - The Luxury of Poverty-Winning against all odds.

  • Dilip Bhat positive on pharma sector Feb 17, 2017 05:06 PM IST

    Dilip Bhat positive on pharma sector

    Dilip Bhat of Prabhudas Lilladher is positive on the pharma sector largely because of the growth factor and because of the profitabilities.

  • Aim to sustain 25% topline growth in FY17: Thyrocare Jan 31, 2017 11:56 AM IST

    Aim to sustain 25% topline growth in FY17: Thyrocare

    Thyrocare Technologies is betting big on the radiology vertical which requires huge capex, but is capable of bringing in good business, says Chairman, CEO & MD A Velumani.

  • Stocks in news: Idea, ICICI Bank, Dilip, NMDC, Motilal Oswal Jan 31, 2017 08:00 AM IST

    Stocks in news: Idea, ICICI Bank, Dilip, NMDC, Motilal Oswal

    Idea Cellular | Maruti Suzuki | ICICI Bank | Dabur India | Dilip Buildcon | Pioneer Distilleries | IL&FS Transportation | Thyrocare | NMDC | SAIL | Emami | Bajaj Finserv | Dish TV | Dalmia Bharat Sugar | Emkay Global | Alankit | Indraprastha Medical and Motilal Oswal are stocks, which are in the news today.

  • Thyrocare chief sees a sales growth of 25% in third quarter Dec 22, 2016 01:00 PM IST

    Thyrocare chief sees a sales growth of 25% in third quarter

    Diagnostics company Thyrocare Technologies felt the blow of demonetisation in the month of November but was back on its feet and saw growth at 24 percent in the month under review.

  • Aurobindo's Hyd unit getting form 483 a non-event: Surajit Pal Dec 20, 2016 10:50 AM IST

    Aurobindo's Hyd unit getting form 483 a non-event: Surajit Pal

    USFDA has issued notice to the Hyderabad unit of Aurobindo Pharma and calming the nerves of the investors Surajit Pal of Prabhudas Lilladher says that it is a non-event and there is no need to worry.

  • Prefer SBI, Britannia, Reliance Capital: Dilip Bhat Oct 30, 2016 09:03 PM IST

    Prefer SBI, Britannia, Reliance Capital: Dilip Bhat

    Dilip Bhat, Joint MD at Prabhudas Lilladher is of the view that one may prefer SBI, Britannia Industries, Reliance Capital and Thyrocare.

  • Not into specific trends; like consumption, auto: Varanium Sep 21, 2016 12:16 PM IST

    Not into specific trends; like consumption, auto: Varanium

    Speaking to CNBC-TV18 TS Anantakrishnan of Varanium Capital Advisors, said he takes a stock-specific approach.

  • Here are SP Tulsian's views on how GST will affect markets Aug 03, 2016 06:48 PM IST

    Here are SP Tulsian's views on how GST will affect markets

    SP Tulsian, sptulsian.com, shares his views on how GST Bill's passage will affect markets. He also talks about NBFC stocks and why he remains cautious about them. Lastly, he explains why he is bullish about Kalyani Steel in the long term.

  • Thyrocare hopeful of growing revenues 25% in FY17 Jul 25, 2016 10:18 AM IST

    Thyrocare hopeful of growing revenues 25% in FY17

    Thyrocare‘s revenue grew 21.7 percent to Rs 69.36 crore and operating profit margins improved to 39.4 percent in the first quarter of FY17.

  • Top buzzing midcap stocks to trade on July 12 Jul 12, 2016 12:45 PM IST

    Top buzzing midcap stocks to trade on July 12

    Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today.

  • Can sustain margins at 40%; a regulator is welcome: Thyrocare Jun 17, 2016 10:47 PM IST

    Can sustain margins at 40%; a regulator is welcome: Thyrocare

    A regulatory body for labs could help the unorganised sector as well as help mitigate risks for companies, says A Velumani, Chairman, CEO & MD of the company.

  • Top buzzing midcap stocks to trade on June 13 Jun 13, 2016 12:30 PM IST

    Top buzzing midcap stocks to trade on June 13

    Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Jindal Steel & Power, L&T, Thyrocare, Balrampur Chini Mills, Dhampur Sugars, Gokaldas and A2Z Infra.

  • To start 25 centres in next 36-48 months: Thyrocare Jun 13, 2016 11:19 AM IST

    To start 25 centres in next 36-48 months: Thyrocare

    The newly listed Thyrocare Technologies aims to maintain the revenue growth of 30 percent in FY17, says the CEO and CMD A Velumani, in an exclusive interview with CNBC-TV18.

  • Top buzzing midcap stocks to trade on June 6 Jun 06, 2016 12:36 PM IST

    Top buzzing midcap stocks to trade on June 6

    Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Biocon, Hotel Leela, Thyrocare, Ujjivan, HDIL, Redington, Jubilant Life, Kwality and Sun Pharma.

  • No revenue-share agreement with doctors, clarifies Thyrocare Jun 06, 2016 09:39 AM IST

    No revenue-share agreement with doctors, clarifies Thyrocare

    Thyrocare neither has any revenue share agreement with doctors nor does it pay them any commissions to send patients to their laboratories, says CMD A Velumani.

  • L&T, Thyrocare, Sun Pharma, Grasim, Biocon among stocks in focus Jun 06, 2016 08:49 AM IST

    L&T, Thyrocare, Sun Pharma, Grasim, Biocon among stocks in focus

    Some of the stocks that should be on your radar are: Larsen and Toubro, Thyrocare Technologies, Bharat Forge, Sun Pharmaceutical Industries, Grasim Industries, Torrent Pharmaceuticals, Adani Enterprises, Biocon, Excel Crop Care, Cadila Healthcare, Jubilant Life Sciences, Kwality.

  • Nifty upside capped at 7,900; +ve on financials barring PSBs: PL May 20, 2016 06:57 PM IST

    Nifty upside capped at 7,900; +ve on financials barring PSBs: PL

    Dilip Bhat says that a combination of recent reforms like the Mauritius Treaty, P-Note amendment and a possible US Fed rate hike in June have been overwhelming for the market in the short term.

Sections
ISO 27001 - BSI Assurance Mark